New scan technique could sharpen cancer imaging
NCT ID NCT07646873
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This pilot study tests a new imaging method called PET-enabled dual-energy CT to measure bone and soft tissue in the bone marrow. It will include 45 adults: some with multiple myeloma scheduled for CAR T-cell therapy and some healthy volunteers. The goal is to see if this new method matches standard X-ray dual-energy CT and whether it can help track treatment response. The study is not expected to directly help participants but may improve future cancer imaging.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
18F-FDG (a radioactive tracer used in PET scans)
What this could lead to
If successful, this could improve how doctors use PET/CT scans to evaluate bone marrow health and treatment response in multiple myeloma.
What could go wrong
This is a very early pilot study with only 45 participants. It is designed to test the imaging method, not to provide direct benefit, so results may not change patient care soon.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MULTIPLE MYELOMA (MM) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
UC Davis EXPLORER Molecular Imaging Center
Sacramento, California, 95816, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact